BFM
CDAK

Boothbay Fund Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Boothbay Fund Management’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,082
Closed -$197K – 2348
2021
Q3 		$197K Buy
+12,082
New +$216K 0.01% 1592

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boothbay Fund Management's CDAK Position: Q4 2021 in Review

Boothbay Fund Management sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q4 2021, closing a stake of 12,082 shares — an estimated $197K sold.

Boothbay Fund Management first reported a position in CDAK in Q3 2021 and held it in 1 quarter. The position peaked at $197K in Q3 2021. 51 funds tracked by Wall St. Rank hold CDAK as of Q4 2021.

  • Boothbay Fund Management reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 12,082 Codiak BioSciences, Inc. Common Stock shares in Q4 2021, an estimated $197K.
  • Boothbay Fund Management first reported a position in Codiak BioSciences, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Boothbay Fund Management's Codiak BioSciences, Inc. Common Stock position peaked at $197K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.